CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease

Henry Ford Health

Status: Enrolling

Conditions: GVHD,Acute

Treatments: Diagnostic Test: blood sample

Study type: Observational

Funder types: Other

Identifiers

NCT05718791

hhf

Details and patient eligibility

About

The prediction of severe acute GVHD before it occurs is of high importance for ensuing clinical decisions and overall success of allogeneic SCT. The key immunologic signatures associated with clinical outcomes after different graft versus host disease prophylaxis methods or peripheral blood stem cell transplant are largely unknown.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients >18 year old admitted for allo SCT PB for malignant disease.